Antibe Therapeutics Inc.
ATBPF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $35 | $72 | $6 |
| Short-Term Investments | $32 | $20 | $0 | $0 |
| Receivables | $2 | $1 | $1 | $2 |
| Inventory | $0 | $0 | $2 | $3 |
| Other Curr. Assets | $1 | $5 | $4 | $0 |
| Total Curr. Assets | $42 | $61 | $79 | $12 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $26 | $26 | $1 | $2 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | -$0 | $0 |
| Other NC Assets | $3 | $1 | $1 | $0 |
| Total NC Assets | $29 | $28 | $3 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $71 | $89 | $82 | $14 |
| Liabilities | – | – | – | – |
| Payables | $0 | $2 | $2 | $4 |
| Short-Term Debt | $0 | $0 | $0 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | -$4 |
| Other Curr. Liab. | $3 | $2 | $1 | $1 |
| Total Curr. Liab. | $3 | $5 | $4 | $8 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $28 | $28 | $28 | $2 |
| Deferred Tax Liab, NC | $0 | $0 | -$0 | -$0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $28 | $28 | $28 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $30 | $32 | $31 | $10 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $141 | $140 | $112 | $50 |
| Retained Earnings | -$130 | -$111 | -$86 | -$60 |
| AOCI | $0 | $10 | $10 | $0 |
| Other Equity | $29 | $18 | $14 | $14 |
| Total Equity | $40 | $57 | $50 | $4 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $71 | $89 | $82 | $14 |
| Net Debt | -$7 | -$35 | -$72 | -$4 |